DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validat…
Sign in to start building your grant-ready profile
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.